Lower-dose vaccine for diphtheria, tetanus, and whooping cough
Part of Infections, Lungs & breathing clinical trials.
This study tests a lower-dose vaccine that protects against diphtheria, tetanus, and whooping cough. It aims to see if the vaccine is safe and how well it works for people aged 6 and older, possibly offering a booster with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 6 years old or older.
- You need valid ID and, if you are under 18, a parent or guardian must be able to sign the consent form.
- You cannot have received any vaccine in the past 30 days, and you must avoid other vaccines for 30 days after the study shot.
- You must be free of acute illnesses like fever or a flare-up of a chronic condition for at least 3 days before joining.
- You cannot have had whooping cough, diphtheria, or tetanus within the past 5 to 10 years.
- You must not have severe allergies, immune problems, or blood clotting issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
This trial tests a new combined vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and how well it works to boost immunity in teens and adults.
This study checks if the protection from an earlier vaccine (against whooping cough, diphtheria, and tetanus) lasts over time. Participants from a previous study will give blood samples to measure their immune response.
This study tests a new type of whooping cough vaccine given to pregnant women to see if it helps protect their babies from whooping cough in the first months of life. The vaccine is given during pregnancy, and then the baby's immune response is checked up to 15–18 months old.
This study tests a new vaccine called BK1803 in healthy infants to see if it is safe and works well. It may help protect against several serious diseases.
This trial tests a new vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy infants who are about 2 months old and live permanently in the area. The goal is to see if the vaccine is safe and works well.
Hear when a new Tetanus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.